INFUSYSTEM HOLDINGS, INC Long-Term Debt
INFUSYSTEM HOLDINGS, INC (INFU) had Long-Term Debt of $20.42 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-04
- 2026-06-30: Long-term Debt, Excluding Current Maturities $20.42M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $19.65M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $19.63M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $20.93M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2026-06-30 | $20.42M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $19.65M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $19.63M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $20.93M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $26.35M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $28.71M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $23.86M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $27.98M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $34.16M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $29.93M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $29.10M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $32.66M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $36.14M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $36.39M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $33.16M 10-K · filed 2024-04-10 | |
| 2022-09-30 | $34.46M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $33.69M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $34.79M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $32.75M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $30.56M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $31.94M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $31.75M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $29.38M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $27.03M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $33.34M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $32.33M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $30.30M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $30.34M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $27.48M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $27.52M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $28.84M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $28.66M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $21.96M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $22.72M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $25.35M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $26.54M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $28.72M 10-Q · filed 2017-08-09 | |
| 2016-12-31 | $26.58M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $31.36M 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $33.48M 10-Q/A · filed 2016-12-12 | |
| 2016-03-31 | $32.43M 10-Q/A · filed 2016-12-12 | |
| 2015-12-31 | $26.55M 10-K · filed 2017-03-22 | $29.88M 10-K · filed 2016-03-09 |
| 2015-09-30 | $29.97M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $28.03M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $28.08M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $19.03M 10-K/A · filed 2016-12-12 | |
| 2014-09-30 | $23.63M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $22.83M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $21.86M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $21.61M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $24.38M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $25.20M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $24.59M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $27.32M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $1.93M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $19.57M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $21.01M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $22.55M 10-K · filed 2013-03-28 | |
| 2011-09-30 | $24.13M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $25.10M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $26.65M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |